Webinar CE Opportunity

The Texas Liver Institute is offering the following learning opportunity: 

Screening, Identifying, and Managing Advanced Liver Disease in Community Centers

Educational Objective

• This is a 2-part education series comprised of 2 one-hour interactive webinars.
• Participants are encouraged to attend both sessions and can earn up to 1.0 CME credit or nursing contact hours for each session attended.

Educational Session 1 (1 hour)

• Overview of liver function and stages of liver disease
• Underlying liver diseases including patient risk factors, epidemiology, screening and diagnosis
• Abnormalities commonly seen on routine labs in patients with advanced liver disease and further workup
• How to perform widespread screening of electronic medical records/patient charts. We have developed an algorithm that can serve as a roadmap in clinical practice.
• Routine surveillance for patients with advanced liver disease, including hepatocellular carcinoma (HCC) and liver transplant
• SIGN UP NOW (select 1 of 2 options):

March 26th, 12:00-1:00 PM CT or March 31st, 6:30-7:30 PM CT

Educational Session 2 (1 hour held 1-2 months after Session 1)

• Faculty will present cases relevant to previous learnings and likely to present at community practices.
• Participants will discuss challenging liver disease cases to expert faculty.
• Participants will discuss implementation of the screening algorithm at their center and any challenges faced.
• Sessions will be scheduled at a later date.

Target Audience

This activity was developed for physicians, nurse practitioners, physician assistants, nurses and other healthcare professionals from community practices in regions that have patient populations with disproportionately high rates of advanced liver disease and hepatocellular carcinoma.

Learning Objectives

At the conclusion of this activity, participants should be better able to:

• Describe straightforward methods to identify patients with possible advanced liver disease and hepatocellular carcinoma in community practices.
• Integrate advances in therapeutic and diagnostic modalities in liver disease into clinical practice.

Faculty

Eugenia Tsai, MD

Transplant Hepatologist
Texas Liver Institute (TLI), San Antonio

Accreditation and Certification

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the Texas Liver Institute. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

This activity is co-provided by the Annenberg Center for Health Sciences at Eisenhower and the Texas Liver Institute.

Annenberg Center for Health Sciences at Eisenhower is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

A maximum of 1.0 contact hours may be earned for successful completion of this activity.

This activity is supported by an independent educational grant from AbbVie, Mallinckrodt and Salix